Endothelial Cell‐Related Proteins in Plasma Predict Major Adverse Cardiovascular Events and Worsening Heart Failure in Patients With Hypertrophic Cardiomyopathy
Journal of the American Heart Association · 2025
DOI: 10.1161/jaha.125.042887 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Shogo Tamura und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences Columbia University New York NY USA. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Heart Failure, Endothelial Cells. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIA NIH HHS.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
Hypertrophic cardiomyopathy (HCM) often causes major adverse cardiovascular events (MACE) and worsening heart failure (HF). Endothelial cell (EC) dysfunction is known to be involved in the pathogenesis of HCM. However, the prognostic value of proteins related to EC function (EC‐related proteins) in HCM is unknown.
Methods
In this prospective cohort study of patients with HCM, we measured plasma levels of 90 EC‐related proteins upon enrollment. The primary outcome measure was MACE. The secondary outcome measure was worsening HF. We developed machine learning models based on EC‐related proteins to predict MACE or worsening HF using data from one institution (training set). We tested the predictive ability in independent samples from the other institution (test set) and performed time‐to‐event analyses.
Results
The study included 722 patients (n=458 in the training set and n=264 in the test set). Using our EC‐related protein‐based model, the area under the receiver‐operating‐characteristic curve to predict MACE was 0.71 (95% CI, 0.64–0.77) and that for worsening HF was 0.71 (95% CI, 0.63–0.79). When we divided the test set into low‐ and high‐risk groups according to the predicted probabilities derived from the training set, the high‐risk groups had significantly higher risks of developing MACE and worsening HF compared with the low‐risk groups (both P logrank
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences Columbia University New York NY USA.
- Division of Cardiology, Department of Medicine Columbia University Irving Medical Center New York NY USA.
- Cardiology Division, Department of Medicine Massachusetts General Hospital, Harvard Medical School Boston MA USA.
ORCID-Profile: Shogo Tamura, Keitaro Akita, Michael A Fifer, Albree Tower-Rader, Mathew S Maurer, Yuichi J Shimada
Förderung
- NHLBI NIH HHS
- NIA NIH HHS
Zitieren
APA
Tamura, S., Akita, K., Fifer, M. A., Tower-Rader, A., Maurer, M. S., & Shimada, Y. J. (2025). Endothelial Cell‐Related Proteins in Plasma Predict Major Adverse Cardiovascular Events and Worsening Heart Failure in Patients With Hypertrophic Cardiomyopathy. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.042887
Vancouver
Tamura S, Akita K, Fifer MA, Tower-Rader A, Maurer MS, Shimada YJ. Endothelial Cell‐Related Proteins in Plasma Predict Major Adverse Cardiovascular Events and Worsening Heart Failure in Patients With Hypertrophic Cardiomyopathy. Journal of the American Heart Association. 2025. doi:10.1161/jaha.125.042887
BibTeX
@article{Tamura2025,
author = {Tamura, Shogo and Akita, Keitaro and Fifer, Michael A and Tower-Rader, Albree and Maurer, Mathew S and Shimada, Yuichi J},
title = {Endothelial Cell‐Related Proteins in Plasma Predict Major Adverse Cardiovascular Events and Worsening Heart Failure in Patients With Hypertrophic Cardiomyopathy},
journal = {Journal of the American Heart Association},
year = {2025},
doi = {10.1161/jaha.125.042887}
}
EUVIMED